Background: Coronavirus disease 2019 (COVID-19) pandemic and lockdown period may induce an impairment in quality of life (QoL), disruption in treatment (DIT), and posttraumatic stress disorder (PTSD) in chronic neurological diseases (CNDs). To reach this information, a multicenter, cross-sectional study (COVQoL-CND) was planned. Parkinson’s disease (PD), headache (HA), multiple sclerosis (MS), epilepsy (EP), polyneuropathy (PNP), and cerebrovascular disease (CVD) were selected as the CND. Methods: The COVQoL-CND study includes demographic data, the World Health Organization Quality of Life short form (WHOQOL-BREF), and Impact of Event Scale-Revised (IES-R) forms. Results: The mean age of a total of 577 patients was 49 ± 17 (19–87 years), and the ratio of female/male was 352/225. The mean age of patients with PD, HA, MS, EP, PNP, and CVD were 65 ± 11, 39 ± 12, 38 ± 10, 47 ± 17, 61 ± 12, and 60 ± 15 years, respectively. The IES-R scores were found to be higher in the younger group, those with comorbid disease, contacted with CO-VID-19 patients, or diagnosed with COVID-19. In the group with a high IES-R score, the rate of DIT was found to be high. IES-R scores were negatively correlated with QoL. IES-R total scores were found highest in the CVD group and lowest in the PD group. The ratio of DIT was found highest in the PNP group and the lowest in the EP group. Contact with CO-VID-19 patients was high in the EP and HA group. Conclusions: The results of the COVQoL-CND study showed that lockdown causes posttraumatic stress and deterioration in the QoL in CND.

1.
Guan
WJ
,
Ni
ZY
,
Hu
Y
,
Liang
WH
,
Ou
CQ
,
He
JX
,
Clinical characteristics of Coronavirus Disease 2019 in China
.
N Engl J Med
.
2020
;
382
(
18
):
1708
20
. .
2.
World Health Organization
.
Novel Coronavirus (2019-nCoV): situation report, 22
.
World Health Organization
;
2020
.
3.
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses
.
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
.
Nat Microbiol
.
2020
;
5
(
4
):
536
44
. .
4.
Wilder-Smith
A
,
Chiew
CJ
,
Lee
VJ
.
Can we contain the covid-19 outbreak with the same measures as for SARS?
Lancet Infect Dis
.
2020
;
20
(
5
):
e102
7
.
5.
Graham
RL
,
Donaldson
EF
,
Baric
RS
.
A decade after SARS: strategies for controlling emerging coronaviruses
.
Nat Rev Microbiol
.
2013
;
11
:
836
48
.
6.
Brooks
SK
,
Webster
RK
,
Smith
LE
,
Woodland
L
,
Wessely
S
,
Greenberg
N
,
The psychological impact of quarantine and how to reduce it: rapid review of the evidence
.
Lancet
.
2020
;
395
(
395
):
912
20
. .
7.
Denes
A
,
Gumel
AB
.
Modeling the impact of quarantine during an outbreak of Ebola virüs disease
.
Infect Dis Model
.
2019
;
4
:
12
27
.
8.
Lau
JT
,
Yang
X
,
Pang
E
,
Tsui
HY
,
Wong
E
,
Wing
YK
.
SARS-related perceptions in Hong Kong
.
Emerg Infect Dis
.
2005
;
11
:
417
24
. .
9.
Monteith
LL
,
Holliday
R
,
Brown
TL
,
Brenner
LA
,
Mohatt
NV
.
Preventing suicide in rural communities during the COVID-19 pandemic
.
J Rural Health
.
2021
;
37
(
1
):
179
84
. .
10.
Rubin
GJ
,
Wessely
S
.
The psychological effects of quarantining a city
.
BMJ
.
2020
;
368
:
m313
. .
11.
Reynolds
DL
,
Garay
JR
,
Deamond
SL
,
Moran
MK
,
Gold
W
,
Styra
R
.
Understanding, compliance and psychological impact of the SARS quarantine experience
.
Epidemiol Infect
.
2008
;
136
:
997
. .
12.
Weiss
DS
,
Marmar
CR
.
The impact of event scale–revised
. In:
Wilson
JP
,
Keane
TM
, editors.
Assessing psychological trauma and PTSD
.
New York
:
Guilford Press
;
1997
. p.
399
411
.
13.
Rash
CJ
,
Coffey
SF
,
Baschnagel
JS
,
Drobes
DJ
,
Saladin
ME
.
Psychometric properties of the IES-R in traumatized substance dependent individuals with and without PTSD
.
Addict Behav
.
2008
;
33
:
1039
47
. .
14.
Asukai
N
,
Kato
H
,
Kawamura
N
,
Kim
Y
,
Yamamoto
K
,
Kishimoto
J
,
Reliability and validity of the Japanese-language version of the Impact of Event Scale-revised (IES-R-J): four studies of different traumatic events
.
J Nerv Ment Dis
.
2002
;
190
:
175
82
. .
15.
Creamer
M
,
Bell
R
,
Failla
S
.
Psychometric properties of the Impact of Event Scale: revised
.
Behav Res Ther
.
2003
;
41
(
12
):
1489
96
. .
16.
Çorapçıoğlu
A
,
Yargıç
İ
,
Geyran
P
,
Kocabaşoğlu
N
.
Olayların Etkisi Ölçeği” (IES-R) Türkçe Versiyonunun Geçerlilik ve Güvenilirliği
.
New/Yeni Symp J
.
2006
;
44
(
1
):
14
22
.
17.
Vanaken
L
,
Scheveneels
S
,
Belmans
E
,
Hermans
D
.
Validation of the impact of event scale with modifications for COVID-19 (IES-COVID19)
.
Front Psychiatry
.
2020
;
11
(
11
):
738
. .
18.
The WHOQOL Group
.
Development of the World Health Organization WHOQOL-BREF quality of life assessment
.
Psychol Med
.
1998
;
28
(
3
):
551
8
. .
19.
Eser
E
,
Fidnner
H
,
Fidaner
C
,
Eser
SY
,
Elbi
H
,
Göker
E
.
WHOQOL-100 ve WHOQOL-BREF'in psikometrik özellikleri
.
Türk Psikiyatri Derg
.
2010
;
21
(
1
):
37
48
.
20.
Guo
YR
,
Cao
QD
,
Hong
ZS
,
Tan
YY
,
Chen
SD
,
Jin
HJ
,
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak: an update on the status
.
Mil Med Res
.
2020 13
;
7
(
1
):
11
. .
21.
Maunder
R
,
Hunter
J
,
Vincent
L
,
Bennett
J
,
Peladeau
N
,
Leszcz
M
,
The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital
.
CMAJ
.
2003
;
168
:
1245
.
22.
Hawryluck
L
,
Gold
WL
,
Robinson
S
,
Pogorski
S
,
Galea
S
,
Styra
R
.
SARS control and psychological effects of quarantine, Toronto, Canada
.
Emerg Infect Dis
.
2004
;
10
:
1206
. .
23.
Leung
GM
,
Lam
TH
,
Ho
LM
,
Ho
SY
,
Chan
BH
,
Wong
IO
,
The impact of community psychological responses on outbreak control for severe acute respiratory syndrome in Hong Kong
.
J Epidemiol Community Health
.
2003
;
57
(
11
):
857
63
. .
24.
Shultz
JM
,
Cooper
JL
,
Baingana
F
,
Oquendo
MA
,
Espinel
Z
,
Althouse
BM
,
The role of fear-related behaviors in the 2013–2016 West Africa ebola virus disease outbreak
.
Curr Psychiatry Rep
.
2016
;
18
(
11
):
104
. .
25.
Al-Mohrej
OA
,
Al-Shirian
SD
,
Al-Otaibi
SK
,
Tamim
HM
,
Masuadi
EM
,
Fakhoury
HM
.
Is the Saudi public aware of Middle East respiratory syndrome?
J Infect Public Health
.
2016
;
9
(
3
):
259
66
.
26.
Zhang
Y
,
Ma
ZF
.
Impact of the COVID-19 pandemic on mental health and quality of life among local residents in Liaoning Province, China: a cross-sectional study
.
Int J Environ Res Public Health
.
2020
;
17
(
7
):
2381
.
27.
Wang
C
,
Pan
R
,
Wan
X
,
Tan
Y
,
Xu
L
,
Ho
CS
,
Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China
.
Int J Environ Res Public Health
.
2020
;
17
(
5
):
1729
. .
28.
Losada-Baltar
A
,
Márquez-González
M
,
Jiménez-Gonzalo
L
,
Pedroso-Chaparro
MDS
,
Gallego-Alberto
L
,
Fernandes-Pires
J
.
[Differences in anxiety, sadness, loneliness and comorbid anxiety and sadness as a function of age and self-perceptions of aging during the lock-out period due to COVID-19]
.
Rev Esp Geriatr Gerontol
.
2020
;
55
(
5
):
272
8
. .
29.
Wang
C
,
Pan
R
,
Wan
X
,
Tan
Y
,
Xu
L
,
McIntyre
RS
,
A longitudinal study on the mental health of general population during the COVID-19 epidemic in China
.
Brain Behav Immun
.
2020
;
87
:
40
8
. .
30.
Huang
Y
,
Zhao
N
.
Chinese mental health burden during the COVID-19 pandemic
.
Asian J Psychiatr
.
2020
;
51
:
102052
. .
31.
Epifanio
MS
,
Andrei
F
,
Mancini
G
,
Agostini
F
,
Piombo
MA
,
Spicuzza
V
,
The impact of COVID-19 pandemic and lockdown measures on quality of life among Italian general population
.
J Clin Med
.
2021
;
10
(
2
):
289
. .
32.
Muris
P
,
Field
AP
.
The role of verbal threat information in the development of childhood fear. “Beware the Jabberwock!”
Clin Child Fam Psychol Rev
.
2010
;
13
:
129
. .
33.
Dubey
S
,
Dubey
MJ
,
Ghosh
R
,
Chatterjee
S
.
Children of frontline COVID-19 warriors: our observations
.
J Pediatr
.
2020
;
224
:
188
9
.
34.
Li
Q
,
Guan
X
,
Wu
P
,
Wang
X
,
Zhou
L
,
Tong
Y
,
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
.
N Engl J Med
.
2020
;
382
:
1199e207
.
35.
Pelicioni
PHS
,
Schulz-Moore
JS
,
Hale
L
,
Canning
CG
,
Lord
SR
.
Lockdown during COVID-19 and the increase of frailty in people with neurological conditions
.
Front Neurol
.
2020
;
11
(
11
):
604299
. .
36.
Dubey
S
,
Biswas
P
,
Ghosh
R
,
Chatterjee
S
,
Dubey
MJ
,
Chatterjee
S
,
Psychosocial impact of COVID-19
.
Diabetes Metab Syndr
.
2020
;
14
(
5
):
779
88
. .
37.
Cao
W
,
Fang
Z
,
Hou
G
,
Han
M
,
Xu
X
,
Dong
J
,
The psychological impact of the COVID-19 epidemic on college students in China
.
Psychiatry Res
.
2020
;
287
:
112934
. .
38.
Gao
J
,
Zheng
P
,
Jia
Y
,
Chen
H
,
Mao
Y
,
Chen
S
,
Mental health problems and social media exposure during COVID-19 outbreak
.
PLoS One
.
2020
;
15
(
4
):
e0231924
. .
39.
Mazza
C
,
Ricci
E
,
Biondi
S
,
Colasanti
M
,
Ferracuti
S
,
Napoli
C
,
A Nationwide survey of psychological distress among Italian people during the COVID-19 Pandemic: immediate psychological responses and associated factors
.
Int J Environ Res Public Health
.
2020
;
17
(
9
):
3165
. .
40.
Lai
J
,
Ma
S
,
Wang
Y
,
Cai
Z
,
Hu
J
,
Wei
N
,
Factors associated with mental health outcomes among health care workers exposed to Coronavirus Disease 2019
.
JAMA Netw Open
.
2020
;
3
(
3
):
e203976
. .
41.
Ozdin
S
,
Bayrak Ozdin
S
.
Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: the importance of gender
.
Int J Soc Psychiatry
.
2020
;
66
(
5
):
504
11
.
42.
Huang
J
,
Liu
F
,
Teng
Z
,
Chen
J
,
Zhao
J
,
Wang
X
,
Care for the psychological status of frontline medical staff fighting against COVID-19
.
Clin Infect Dis
.
2020; 15
;
71
(
12
):
3268
9
. .
43.
Du
J
,
Dong
L
,
Wang
T
,
Yuan
C
,
Fu
R
,
Zhang
L
,
Psychological symptoms among frontline healthcare workers during COVID-19 outbreak in Wuhan
.
Gen Hosp Psychiatry
.
2020
;
67
:
144
5
. .
44.
Mo
Y
,
Deng
L
,
Zhang
L
,
Lang
Q
,
Liao
C
,
Wang
N
,
Work stress among Chinese nurses to support Wuhan for fighting against the COVID-19 epidemic
.
J Nurs Manag
.
2020
;
28
(
5
):
1002
9
.
45.
Litman
T
.
Lessons from pandemics: comparing urban and rural risks
;
2020
. Available from: https://www.planetizen.com/blogs/109051-lessons-pandemics-comparing-urban-and-rural-risks Accessed 2020 Apr 14.
46.
Thaller
M
,
Tsermoulas
G
,
Sun
R
,
Mollan
SP
,
Sinclair
AJ
.
Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension
.
J Neurol Neurosurg Psychiatry
.
2021
;
92
(
7
):
795
97
.
47.
Sylaja
PN
,
Srivastava
MVP
,
Shah
S
,
Bhatia
R
,
Khurana
D
,
Sharma
A
,
The SARS-CoV-2/COVID-19 pandemic and challenges in stroke care in India
.
Ann N Y Acad Sci
.
2020
;
1473
(
1
):
3
10
. .
48.
Liu
N
,
Zhang
F
,
Wei
C
,
Jia
Y
,
Shang
Z
,
Sun
L
,
Prevalence and predictors of PTSS during COVID-19 outbreak in China hardest-hit areas: gender differences matter
.
Psychiatry Res
.
2020
;
287
:
112921
.
49.
Bo
HX
,
Li
W
,
Yang
Y
,
Wang
Y
,
Zhang
Q
,
Cheung
T
,
Posttraumatic stress symptoms and attitude toward crisis mental health services among clinically stable patients with COVID-19 in China
.
Psychol Med
.
2020
;
27
:
1
2
. .
50.
Cilia
R
,
Bonvegna
S
,
Straccia
G
,
Andreasi
NG
,
Elia
AE
,
Romito
LM
,
Effects of COVID-19 on Parkinson’s disease clinical features: a community-based case-control study
.
Mov Disord
.
2020
;
35
(
8
):
1287
92
. .
51.
Helmich
RC
,
Bloem
BR
.
The Impact of the COVID-19 pandemic on Parkinson's Disease: hidden sorrows and emerging opportunities
.
J Parkinsons Dis
.
2020
;
10
(
2
):
351
4
. .
52.
Uygun
Ö
,
Ertaş
M
,
Ekizoğlu
E
,
Bolay
H
,
Özge
A
,
Kocasoy Orhan
E
,
Headache characteristics in COVID-19 pandemic: a survey study
.
J Headache Pain
.
2020
;
21
(
1
):
121
. .
53.
Pandey
D
,
Bansal
S
,
Goyal
S
,
Garg
A
,
Sethi
N
,
Pothiyill
DI
,
Psychological impact of mass quarantine on population during pandemics: the COVID-19 Lock - Down (COLD) study
.
PLoS One
.
2020
;
15
(
10
):
e0240501
.
54.
Sormani
MP
.
Italian Study Group on COVID-19 infection in multiple sclerosis. An Italian programme for COVID-19 infection in multiple sclerosis
.
Lancet Neurol
.
2020
;
19
(
6
):
481
2
.
55.
Haji Akhoundi
F
,
Sahraian
MA
,
Naser Moghadasi
A
.
Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients
.
Mult Scler Relat Disord
.
2020
;
41
:
102164
. .
56.
Moss
BP
,
Mahajan
KR
,
Bermel
RA
,
Hellisz
K
,
Hua
LH
,
Hudec
T
,
Multiple sclerosis management during the COVID-19 pandemic
.
Mult Scler
.
2020
;
26
(
10
):
1163
71
. .
57.
French
JA
,
Brodie
MJ
,
Caraballo
R
,
Devinsky
O
,
Ding
D
,
Jehi
L
,
Keeping people with epilepsy safe during the COVID-19 pandemic
.
Neurology
.
2020; 9
;
94
(
23
):
1032
7
. .
58.
Adan
GH
,
Mitchell
JW
,
Marson
T
.
Epilepsy care in the COVID-19 era
.
Clin Med
.
2020
;
20
(
4
):
e104
6
. .
59.
Munhoz
RP
,
Pedroso
JL
,
Nascimento
FA
,
Almeida
SM
,
Barsottini
OGP
,
Cardoso
FEC
,
Neurological complications in patients with SARS-CoV-2 infection: a systematic review
.
Arq Neuropsiquiatr
.
2020
;
78
(
5
):
290
300
. .
60.
Bersano
A
,
Kraemer
M
,
Touzé
E
,
Weber
R
,
Alamowitch
S
,
Sibon
I
,
Stroke care during the COVID-19 pandemic: experience from three large European countries
.
Eur J Neurol
.
2020
;
27
(
9
):
1794
800
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.